Associate Chief Hematology, Director- Blood and Marrow Transplant,
San Francisco, CA
Joined December 2016
- Tweets248
- Following163
- Followers3.5K
- Likes117
Tom Martin retweeted
SOHO congratulates @Santin13Valeria on assuming the role of Society President for the 2026–2027 term, during which she'll also chair the Fifteenth Annual Meeting of SOHO in Houston, Texas.
Read more: sohoinsider.com/society-upda…
Screening for MGUS is an important question being answered by iStopMM trial - results potentially ready in 2027 - we will need many more Hematologists @iStopMM , @UCSFCancer, @IMFmyeloma
A truly Amazing Physician, Scientist, Mentor and Person. His contributions to myeloma and medicine are beyond measurable. He will be missed dearly and our best to the Mayo Community!!!❤️
Profound sorry that my mentor, friend, and colleague, the legend Bob Kyle passed away. His contributions to patients, medicine, myeloma, @IMFmyeloma @MayoClinic myeloma group, and the institution are monumental. A role model who will be remembered for his integrity and commitment to patients. I owe my career to him. He leaves behind a legacy of experts at Mayo Clinic as well as world over who were influenced greatly by him.
See thread for links to a video an article on him that I wrote for @MayoProceedings
Post your memories below.
Congrats - great work
As bispecific antibodies move up in earlier lines, every myeloma physician/center will need to deliver these drugs. Here is our review for implementing these therapies @CarlynRTanMD @szusmani @MyelomaCanada @HamiltonMyeloma @HamHealthSci @McMasterU @JCOOP_ASCO @MSKCancerCenter
Tom Martin retweeted
Room full at our IMWG immunotherapy meeting, thank you everyone for the great discussions #IMWG2026 with @TomBmt133 @YiLinMDPhD
🤖 Made with AI
Amazing Physician, Researcher and Colleague - so well deserved - ayes an inspiration to us all!!!!
@NoopurRajeMD is simply a world class myeloma doctor and a world class human being. One of the most influential doctors in this space and an inspiration to patients and colleagues alike. Such a well deserved award @IMFmyeloma #mmsm
Inaugural “Harvesting Myeloma” CME program in Napa Valley - Chaired by Ajai Chari with Peter V and Ajay N giving first two talks - packed house with Vaniam Group providing awesome setting/support mark your calendar for 2027
Tom Martin retweeted
"Accelerating.. bispecific adoption...is the highest impact goal that the research community can currently undertake."
@MileHighMyeloma & @LNastoupilMD talk managing access to novel agents in the community setting.
buff.ly/IuEmB39
If you haven’t seen this … it’s worth a read for all CAR enthusiasts. Eyquem lab - in Nature published site specific integration of in vivo CAR into the TRAC locus: anti BCMA,CD19, B7H3 CARs - all effective in NSG mice models @Myeloma_Society #mmsm
And higher expression in HR -MM - looking forward to clinical trial
Nice work by @apwiita at @Myeloma_Society 7th Immune Effector Workshop showing why CD27 N88A may be best anti-CD70 CAR binder and how this AA impacts dissociation from CD70 #mmsm
Amazing times … with many immunotherapy trials destined to answer the questions; cart 5/6, triumph, Master2, radar, EMN30, Linker-MM4,Midas ELLEN, HD-10, inMMyCAR, to name a few - every conference will share new insights!!
March is Myeloma Action Month - so just started training for the IMF Iceland Cycling Expedition in August I. The distance is SF - have plenty of training to do
Yes, very important to quickly define optimal duration but this will be optimized in Real World efforts. At ASH more than 1300 Tec patients described in RW abstracts
Agree and we will make sure we have guidelines on this quick. Yi and Tom are aware of the importance of this. @YiLinMDPhD @TomBmt133
Late Breaking ASH: Congrats to Mavie V and Tec-3 investigators. Practice changing and results we will ALL remember as part of ASH2025!!!
DR Chung showing increased sustained MRD (-) rates - in those receiving Dara- Len vs Lem maintenance in the Aurora trial !
Tom Martin retweeted
Very exciting. Welcome Heather!
*Press Release*
The International Myeloma Foundation announced Heather Cooper Ortner — President & CEO of Alzheimer’s Los Angeles, & former CEO of the Dr. Susan Love Research Foundation — has been named as the IMF’s new President & Chief Executive Officer.
globenewswire.com/news-relea…
